Literature DB >> 19289760

Neurolymphomatosis associated with Sézary syndrome.

Maud Bezier1, Ziad Reguiaï, Philippe Delaby, Liliane Laroche, Gérard Saïd, Philippe Bernard, Florent Grange.   

Abstract

BACKGROUND: Mycosis fungoides and Sézary syndrome are cutaneous T-cell lymphomas characterized by the epidermotropism of tumor cells. Neuropathic disease is rare during mycosis fungoides and Sézary syndrome and usually results from a central nervous system involvement in late stages. Neurolymphomatosis is defined as the infiltration of the peripheral nerves by tumor lymphocytes. It has been described in patients with aggressive systemic lymphomas but, to our knowledge, not in patients with mycosis fungoides or Sézary syndrome. We report the first case of neurolymphomatosis in a patient with Sézary syndrome and the partial efficacy of high-dose methotrexate sodium in treating this usually refractory complication. OBSERVATION: A 73-year-old woman with newly diagnosed Sézary syndrome rapidly developed severe peripheral neuropathic disease with multiple paralyses. Biopsy specimens were taken from a clinically affected nerve and the adjacent muscle; they revealed a neural infiltration by Sézary cells with secondary muscular atrophy. Partial response and major neurologic recovery occurred and persisted under high doses of intravenous methotrexate until the patient died 14 months after the Sézary syndrome diagnosis from a pericarditis of uncertain origin.
CONCLUSION: This unusual and demonstrative case report highlights the possible neurotropism of malignant cells in Sézary syndrome and suggests the effectiveness of high doses of intravenous methotrexate in this rare and fatal disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19289760     DOI: 10.1001/archdermatol.2008.584

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal
Journal:  Blood       Date:  2010-04-05       Impact factor: 22.113

2.  Progressive neurolymphomatosis with cutaneous disease: response in a patient with mycosis fungoides.

Authors:  Ramez Hanna; Gina A Di Primio; Mark Schweitzer; Carlos Torres; Adnan Sheikh; Santanu Chakraborty
Journal:  Skeletal Radiol       Date:  2013-03-27       Impact factor: 2.199

3.  Peripheral neuropathy in sézary syndrome: coincidence or a part of the syndrome?

Authors:  Yeşim S Karadağ; Aydın Gülünay; Neşe Oztekin; Fikri Ak; Saadettin Kılıçkap
Journal:  Turk J Haematol       Date:  2013-12-05       Impact factor: 1.831

4.  Neurolymphomatosis in Primary Cutaneous CD4+ Pleomorphic Small/Medium-sized T-cell Lymphoma Mimicking Hansen's Disease.

Authors:  Anza Khader; Mary Vineetha; Mamatha George; Shiny Padinjarayil Manakkad; Sunitha Balakrishnan; Uma Rajan
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

5.  Diagnostic delay in a case of T-cell neurolymphomatosis.

Authors:  Vivien Li; Zane Jaunmuktane; Kate Cwynarski; Aisling Carr
Journal:  BMJ Case Rep       Date:  2019-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.